Biochemical modulation of 5-fluorouracil with murine interferon-α/β against murine renal cell carcinoma

International Journal of Urology

Volumn 4, Issue 2, 1997, Pages 163-168

  Marumo, Ken ^a,b   Oya, Mototsugu ^a   Murai, Masaru ^a  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO ELECTRIC POWER COMPANY   (Japan)

Author keywords

5 fluorouracil; Biochemical modulation; Interferon; Mouse; Renal cell carcinoma

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BETA INTERFERON; FLUOROURACIL; THYMIDINE KINASE; THYMIDINE PHOSPHATE; THYMIDYLATE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCHEMISTRY; CANCER CELL CULTURE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; FEMALE; KIDNEY CARCINOMA; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030965515     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1997.tb00164.x     Document Type: Article

References (30)

1. Patel NP, Lavengood RW. Renal cell carcinoma: natural history and results of treatment. J Urol 1977; 119:722-726.
2. Paucker K, Cantell K, Henle W. Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of cells. Virology 1962;17:324-334.
3. Pestka S, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Ann Rev Biochem 1987;56:727-778.
4. Quesada JR, Swanson DA, Trindade A, Gutterman JU. Renal cell carcinoma: antitumor effects of leukocyte interferon. Cancer Res 1983;43:940-947.
5. deKernion JB, Sarna G, Figlin R, Lindner A, Smith RB. The treatment of renal cell carcinoma with human leukocyte alpha-interferon. J Urol 1983;130:1063-1066.
6. Marumo K, Murai M, Hayakawa M, Tazaki H. Human lymphoblastoid interferon therapy for advanced renal cell carcinoma. Urology 1984;24:567-571.
7. Kirkwood JM, Harris JE, Vera R, Sandler S, Fischer DS, Khandekar J, Ernstoff MS, Gordon L, Lutes R, Bonomi P, Lytton B, Cobleigh M, Taylor SJ. A randomized study of low and high doses of leukocyte α-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial. Cancer Res 1985;45:863-871.
8. Quesada JR, Kurzrock R, Sherwin SA, Gutterman JU. Phase II studies of recombinant human interferon gamma in metastatic renal cell carcinoma. J Biol Response Mod 1987;6:20-27.
9. Schulof R, Lokich J, Wampler G, Schulz G, Ahlgren J. Phase II trial of protracted infusional 5-FU (PIF) for metastatic renal cell carcinoma (RCC). Proc Am Soc Clin Oncol 1991;10:170.
10. Kish JA, Neefe JR, Flanigan R. Efficacy of low dose continuous infusion 5-fluorouracil (LDCI-5FU) in recurrent/metastatic (r/m) renal cell carcinoma (RCC). Southwest Oncology Group (SWOG) study. Proc Am Assoc Cancer Res 1991;32:186.
11. Spears CP, Shahinian AH, Moran RG, Heidelberger C, Corbett TH. In vivo kinetics of thymidylate synthetase inhibition in 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Cancer Res 1982; 42:450-456.
12. Spears CP, Gustavsson BG, Mitchell MS, Spicer D, Berne M, Bernstein L, Danenberg PV. Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. Cancer Res 1984;44:4144-4180.
13. Namba M, Miyoshi T, Kanamori T, Nobuhara M, Kimoto T, Ogawa S. Combined effects of 5-fluorouracil and interferon on proliferation of human neoplastic cells in culture. Jpn J Cancer Res 1982; 73:819-824.
14. Le J, Yip YK, Vilcek J. Cytolytic activity of interferon-gamrna and its synergism with 5-fluorouracil. Int J Cancer 1984;34:495-500.
15. Iigo M, Chapekar MS, Glazer RI. Syncrgistic antitumor effect of fluoropyrimidines and polyinosinic-polycytidylic acid against L1210 leukemia. Cancer Res 1985;45:4039-4042.
16. Gewert DR, Shah S, Clemens MJ. Inhibition of cell division by interferons. Changes in the transport and intracellular metabolism of thymidine in human lymphoblastoid (Daudi) cells. Eur J Biochem 1981;116:487-492.
17. Murphy GP, Hrushesky WJ. A murine renal cell carcinoma. J Natl Cancer Inst 1973;50:1013-1025.
18. Ishikura K, Fujioka T, Hasegawa M, Nomura K, Okamoto T, Tanji S, Kubo T. In vivo antitumor effect of combination therapy with α/β-interferon and γ-interferon on a murine renal cell carcinoma. J Jpn Soc Cancer Ther 1992;27:2020-2027.
19. Taylor AT, Stafford MA, Jones OW. Properties of thymidine kinase partially purified from human fetal and adult tissue. J Biol Chem 1972;247:1930-1935.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
21. Chu E, Zinn S, Boarman D, Allegra CJ. Interaction of γ interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Cancer Res 1990;50:5834-5840.
22. Swain SM, Lippman ME, Egan EF, Drake JC Steinberg SM, Allegra CJ. 5-Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer. J Clin Oncol 1989;7:890-899.
23. Elias L, Crissman HA. Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites. Cancer Res 1988;48:4868-4873.
24. Kubota T, Fujita S, Kodaira S, Yamamoto T, Josui K, Arisawa Y, Suto A, Ishibiki K, Abe O, Mabuchi K, Fuse M. Antitumor activity of fluoropyrimidines and thymidylate synthetase inhibition. Jpn J Cancer Res 1991;82:476-482.
25. Fuse A, Kuwata T. Inhibition of DNA synthesis of synchronized RSa cells by human leukocyte interferon. J Natl Cancer Inst 1977;58:891-895.
26. Brouty-Boyé D, Tovey MG. Inhibition by interferon of thymidine uptake in chemostat cultures of L1210 cells. Intervirology 1978;9:243-252.
27. Lundgren E, Larsson I, Miörner H, Strannegård Ö. Effects of leukocyte and fibroblast interferon on events in the fibroblast cell cycle. J Gen Virol 1979;42:589-595.
28. Gewert DR, Moore G, Clemens MJ. Inhibition of cell division by interferons. The relationship between changes in utilization of thymidine for DNA synthesis and control of proliferation in Daudi cells. Biochem J 1983;214:983-990.
29. Hänninen EL, Kirchner H, Atzpodien J. Interleukin-2 based home therapy of metastatic renal cell carcinoma: Risk and benefits in 215 consecutive single institution patients. J Urol 1996;155:19-25.
30. Igarashi T, Marumo K, Onishi T, Kobayashi M, Satomi Y, Aiba K, Kawamura J. Interferon-alpha plus 5-FU therapy in metastatic renal cell cancer: a multicenter trial by the Japanese Study Group Against Renal Cancer. Proc Am Soc Clin Oncol 1996;15:257.